Abrams Eye Center
Cleveland, Ohio, United States
Doctor in Cleveland, Ohio
2322 E 22nd St #102, Cleveland, OH 44115
About Abrams Eye Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Kala Pharmaceuticals, Inc.
3
Merck Sharp & Dohme LLC
3
Santen Inc.
3
RVL Pharmaceuticals, Inc.
2
Aerie Pharmaceuticals
1
Aerpio Therapeutics
1
Ocugen
1
Ocuphire Pharma, Inc.
1
OmegaD LLC
1
Rigel Pharmaceuticals
1
Shire
1
Clinical Trials at Abrams Eye Center
During the past decade, Abrams Eye Center conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 10 clinical trials were completed, i.e. on
average, 76.9% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 8 clinical trials were completed. i.e. 400%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003)
2004-07-01
2006-01-01
Completed
685
The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Two-Week Treatment Period
2009-04-01
2010-01-01
Completed
313
A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Dry Eye Disease
2009-10-01
2010-03-01
Completed
112
AR-12286 Fixed Dose Combination to Lower Elevated Intraocular Pressure
2011-12-01
2012-04-01
Completed
93
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
2013-07-01
2014-07-01
Completed
204
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
2014-06-01
2015-03-01
Completed
150
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
2014-07-01
2016-06-01
Completed
206
A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)
2014-11-06
2015-10-05
Completed
711
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Abrams Eye Center" #1 sponsor was "Kala Pharmaceuticals, Inc." with 3 trials, followed by "Merck Sharp & Dohme LLC" with 3 trials
sponsored, "Santen Inc." with 3 trials sponsored, "RVL Pharmaceuticals, Inc." with 2 trials sponsored and "Aerie Pharmaceuticals"
with 2 trials sponsored. Other sponsors include 4 different institutions and
companies that sponsored additional 14 trials in total.
Clinical Trials Conditions at Abrams Eye Center
According to Clinical.Site data, the most researched conditions in "Abrams Eye Center" are
"Dry Eye" (4 trials), "Keratoconjunctivitis Sicca" (3 trials), "Ocular Hypertension" (3 trials), "Blepharitis" (2 trials) and "Blepharoptosis" (2 trials). Many other conditions were trialed in "Abrams Eye Center" in a lesser frequency.
Clinical Trials Intervention Types at Abrams Eye Center
Most popular intervention types in "Abrams Eye Center" are "Drug" (21 trials) and "Other" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Vehicle" (3 trials), "DE-117 Ophthalmic Solution" (2 trials), "KPI-121" (2 trials) and "Placebos" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Abrams Eye Center
The vast majority of trials in "Abrams Eye Center" are
21 trials for "All" genders.
Clinical Trials Status at Abrams Eye Center
Currently, there are NaN active trials in "Abrams Eye Center".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 17 completed trials in Abrams Eye Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Abrams Eye Center, 1 "Phase 1"
clinical trials were conducted, 10 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".